ArticleCommunications biology2025
Phage engineering to overcome bacterial Tmn immunity in Dhillonvirus.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Review
- Addressing antimicrobial resistance: Current challenges, emerging strategies, and an AI-powered, community-driven approach.PNAS nexus · 2026Review
- Bacterial immune systems.Antonie van Leeuwenhoek · 2026Review
- Expanding the Antimicrobial Toolbox with Therapeutic Viruses: Mechanisms, Pharmaceutical Formulation, and Translational Outlook.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Towards accurate artificial intelligence models for strain-level phage-host prediction.Briefings in bioinformatics · 2026Article
- Optimizing phage therapy with antidefense proteins acquired from the environment.Frontiers in microbiology · 2026Article
- Viral Dark Matter: Illuminating Protein Function, Ecology, and Biotechnological Promises.Biochemistry · 2025Review
- PEGylation Overcomes Pharmacological Barriers to Improve Systemic Pharmacokinetics and Therapeutic Efficacy of Phages against MDRJournal of microbiology and biotechnology · 2025Article
- Advanced Strategies in Phage Research: Innovations, Applications, and Challenges.Microorganisms · 2025Review
- Isolation and characterization of novel bacteriophages targeting Stenotrophomonas maltophilia.Scientific reports · 2025Article
- Biocontrol of Phage Resistance inViruses · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Bacteria possess numerous defense systems against phage infections, which limit phage infectivity and pose challenges for phage therapy. This study aimed to engineer phages capable of evading these defense systems, using the Tmn defense system as a model. We identified an anti-Tmn protein in the ΦSMS22 phage from the Dhillonvirus genus that inhibits Tmn function in Escherichia coli. Introducing this gene into the Tmn-sensitive ΦKSS9 phage enabled it to evade Tmn immunity. Additionally, we found that a single mutation in the nmad5 gene, a DNA modification enzyme in Dhillonvirus, prevented Tmn from sensing phage infection. By mutating the nmad5 gene in the Tmn-sensitive Dhillonvirus, we demonstrated that engineering phages to evade bacterial sensing mechanisms is another viable strategy. These two phage engineering approaches-introducing anti-defense genes and mutating sensing-related genes-present a promising strategy for establishing effective phage therapy by neutralizing bacterial defense systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.